Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the market right now?

The expansion of the resorbable vascular scaffolds market has been rapid in the past few years. This market is slated to develop from a valuation of $0.46 billion in 2024 to a value of $0.52 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.9%. The significant growth observed in the historic period can be attributed to factors such as the growing incidence of cardiovascular ailments, heightened health consciousness among consumers, a rising number of coronary artery disease (CAD) cases, increased preference for minimally invasive procedures, and a growing diabetes patient population.

How fast Is the market expected to grow, and what’s its future value?

In the upcoming years, the resorbable vascular scaffolds market is projected to experience swift expansion, with its value escalating to $0.83 billion in 2029, reflecting a compound annual growth rate (CAGR) of 12.6%. This anticipated increase during the forecast period can be associated with the escalating risk of coronary artery disease (CAD) and peripheral artery disease (PAD) in the elderly, escalating funds for research and advancement of surgical protocols, an expanding aging populace, a surge in healthcare expenditure, and the growing prevalence of coronary artery disease. The forecast period will likely see a predilection towards drug-eluting devices for angioplasty, technological progress and product innovation, advancements in stent technology, and improvements in diagnostic technologies as notable market trends.

Get your market report here!

https://www.thebusinessresearchcompany.com/report/resorbable-vascular-scaffolds-global-market-report

What are the major factors driving growth in the market?

The surging incidence of cardiovascular diseases is set to fuel expansion in the resorbable vascular scaffolds market. Risk factors for these heart conditions include poor lifestyle choices, the aging process, hypertension, high cholesterol levels, diabetes, tobacco consumption, and genetic propensities. Resorbable vascular scaffolds are revolutionizing how cardiovascular diseases are treated, by temporarily bolstering structure to recover blood flow, while eventually dissolving. This minimizes the risk of long-term complications tied to permanent implants and fosters natural healing and functionality of vessels. For example, per the Minnesota Department of Health, a state agency based in the US, about 4%, or nearly 180,000 Minnesotan adults had suffered a heart attack in 2023. Moreover, heart disease was identified as the cause of nearly 17% of all deaths in the state, culminating in 8,972 casualties in 2022. Consequently, the escalating occurrence of cardiovascular diseases is propelling the growth trajectory of the resorbable vascular scaffolds market.

What are the key segments defining the market?

The resorbable vascular scaffolds market covered in this report is segmented –

1) By Product Design: Multilumen, Single Lumen

2) By Material Type: Poly-Glycolic Acid, Poly-L-Lactic Acid, Poly-L-Lactic-Co-Glycolic Acid

3) By Deployment Technique: Balloon-Expandable, Self-Expandable

4) By Application: Coronary Artery Disease, Peripheral Vascular Disease, Pulmonary Artery Disease

5) By End User: Ambulatory Surgical Centers, Hospitals, Specialty Clinics

Subsegments:

1) By Multilumen: Helical Design, Braided Design, Other Multilumen Designs

2) By Single Lumen: Straight Tube Design, Corrugated Tube Design, Other Single Lumen Designs

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21272&type=smp

Who are the key players steering the development of the market?

Major companies operating in the resorbable vascular scaffolds market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Getinge Group, Biotronik, LivaNova plc, Lepu Medical Technology, Gore Medical, Biosensors International, Blue Medical, Reva Medical, Elixir Medical, S3V Vascular Technologies, Amaranth Medical Inc., Meril Life Sciences Pvt. Ltd., Arterius Limited, Zorion Medical, Kyoto Medical Planning Co. Ltd., ICON Interventional Systems.

What are the key trends shaping the future of the market?

Prominent players in the resorbable vascular scaffolds market are innovating with magnesium scaffolds to enhance biocompatibility and furnish superior mechanical back-up. Unlike the traditional polymer-based scaffolds, these magnesium scaffolds facilitate natural vessel recovery while diminishing inflammatory response and complications. For example, Biotronik, a medical device firm based out of Germany, was granted a breakthrough device designation by the Food and Drug Administration (FDA) in March 2024, for its Freesolve below-the-knee resorbable magnesium scaffold (BTK RMS). The Freesolve RMS, an innovative device designed for patients suffering from chronic limb-threatening ischemia (CLTI), presents a cutting-edge therapy choice for below-the-knee (BTK) interventions. The device incorporates BIOmag magnesium alloy and Orsiro drug-eluting stent (DES) coating technology which augments its safety, deliverability, and vessel support capabilities. The scaffold renders temporary support to thwart vessel recoil during the healing process.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21272

Which regions are most influential in expanding the market?

North America was the largest region in the resorbable vascular scaffolds market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the resorbable vascular scaffolds market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cell Regeneration Medicine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-regeneration-medicine-global-market-report

Generalized Anxiety Disorder Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/generalized-anxiety-disorder-global-market-report

Specialty Generics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: